Navigation Links
Cepheid to Webcast Analyst Event
Date:7/21/2008

Management presentations to be hosted at 2008 American Association for

Clinical Chemistry Annual Meeting

SUNNYVALE, Calif., July 21 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD) today invited investors to participate in the Company's Analyst Reception which is being hosted in Washington, D.C. ahead of the 2008 American Association for Clinical Chemistry (AACC) Annual Meeting.

Cepheid speakers will include Chief Executive Officer John Bishop, Chief Medical and Technology Officer David Persing, Chief Operations Officer Humberto Reyes, Senior Vice President of Worldwide Commercial Operations, Rob Koska, and Chief Financial Officer Andrew Miller.

Investors and interested parties are welcome to access the live webcast that will be available starting at 5:30 p.m. Eastern Time on Monday, July 28, 2008. The program is expected to last up to three hours. To access the live webcast, please visit Cepheid's website at http://www.cepheid.com/investors at least 15 minutes before the scheduled start time to download any necessary audio or plug-in software. A replay of the webcast will be available shortly following the call and will remain available for at least 90 days.

About Cepheid

Cepheid (Nasdaq: CPHD), based in Sunnyvale, Calif., is an on-demand molecular diagnostics company that develops, manufactures, and markets fully-integrated systems and tests for genetic analysis in the clinical, industrial and biothreat markets. The Company's systems enable rapid, sophisticated genetic testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. Cepheid's easy-to-use systems integrate a number of complicated and time-intensive steps, including sample preparation, DNA amplification and detection, which enable the analysis of complex biological samples in its proprietary test cartridges. Through its strong molecular biology capabilities, the Company is focusing on those applications where rapid molecular testing is particularly important, such as identifying infectious disease and cancer in the clinical market; food, agricultural, and environmental testing in the industrial market; and identifying bio-terrorism agents in the biothreat market.

For Media Inquiries:

Jared Tipton

Cepheid Corporate Communications

Tel: (408) 400 8377

jared.tipton@cepheid.com

For Investor Inquiries:

Jacquie Ross

Cepheid Investor Relations

Tel: (408) 400 8329

jacquie.ross@cepheid.com


'/>"/>
SOURCE Cepheid
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Cepheid Schedules Fiscal 2008 Second Quarter Financial Results Announcement and Webcast
2. Noted Molecular Epidemiologist Joins Cepheid to Head Healthcare Associated Infection Consortium Program
3. Cepheid Market Reach Extended with Licenses in Canada and Registrations in Mexico
4. Cepheid Signs Group Purchasing Contract with Novation, the Nations Largest Healthcare Contracting Organization
5. Cepheid to Present at the Robert W. Baird Growth Stock Conference and the Bank of America Healthcare Conference
6. Cepheid Schedules Teleconference and Webcast for First Quarter 2008 Results
7. Cepheid to Present at Cowen and Companys 28th Annual Healthcare Conference
8. Cepheid Reports Fourth Quarter and Full Year 2007 Results
9. Cepheid and Instrumentation Laboratory Introduce Xpert(TM) HemosIL(R) FII & FV Assay to European Clinical Testing Market
10. Cepheid Appoints Senior VP, Chief Financial Officer to Management Team
11. Cepheid Schedules Teleconference and Webcast for 2007 Fourth Quarter and Full Year Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/9/2017)... , Oct. 9, 2017  BioTech Holdings announced ... by which its ProCell stem cell therapy prevents ... ischemia.  The Company, demonstrated that treatment with ProCell ... limbs saved as compared to standard bone marrow ... HGF resulted in reduction of therapeutic effect.  ...
(Date:10/9/2017)... ... October 09, 2017 , ... At its national board meeting in North Carolina, ... Harvard University’s Departments of Physics and Astronomy, has been selected for membership in ... team for the 2015 Breakthrough Prize in Fundamental physics for the discovery of the ...
(Date:10/9/2017)... ... October 09, 2017 , ... ... 5, 2017, in the medical journal, Epilepsia, Brain Sentinel’s SPEAC® System which ... video EEG, in detecting generalized tonic-clonic seizures (GTCS) using surface electromyography (sEMG). ...
(Date:10/7/2017)... ... October 06, 2017 , ... ... its ProxiMeta™ Hi-C metagenome deconvolution product, featuring the first commercially available Hi-C ... software to perform Hi-C metagenome deconvolution using their own facilities, supplementing the ...
Breaking Biology Technology:
(Date:4/11/2017)... , April 11, 2017 NXT-ID, Inc. ... technology company, announces the appointment of independent Directors Mr. ... to its Board of Directors, furthering the company,s corporate governance ... Gino ... we look forward to their guidance and benefiting from their ...
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... anticipated to expand at a CAGR of 25.76% during ... diseases is the primary factor for the growth of ... report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global ... product, technology, application, and geography. The stem cell market ...
(Date:3/30/2017)... The research team of The Hong Kong Polytechnic University ... adopting ground breaking 3D fingerprint minutiae recovery and matching technology, pushing ... for use in identification, crime investigation, immigration control, security of access ... ... A research team led by Dr Ajay ...
Breaking Biology News(10 mins):